CHINA PHARMA HOLDINGS, INC. Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount of $1.12 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-01.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate · last filed 2026-04-01
- CHINA PHARMA HOLDINGS, INC. effective income tax rate reconciliation, change in enacted tax rate, amount for fiscal 2025 was $1.12K, a 20.19% increase from fiscal 2024.
- CHINA PHARMA HOLDINGS, INC. effective income tax rate reconciliation, change in enacted tax rate, amount for fiscal 2024 was $931.00, a 72.47% decline from fiscal 2023.
- CHINA PHARMA HOLDINGS, INC. effective income tax rate reconciliation, change in enacted tax rate, amount for fiscal 2023 was $3.38K, a 59.81% decline from fiscal 2022.
- CHINA PHARMA HOLDINGS, INC. effective income tax rate reconciliation, change in enacted tax rate, amount for fiscal 2022 was $8.42K, a 0.28% decline from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount 12 month |
|---|---|
| 2025-12-31 | $1.12K 10-K · filed 2026-04-01 |
| 2024-12-31 | $931.00 10-K · filed 2026-04-01 |
| 2023-12-31 | $3.38K 10-K · filed 2025-03-31 |
| 2022-12-31 | $8.42K 10-K · filed 2024-04-01 |
| 2021-12-31 | $8.44K 10-K · filed 2023-03-30 |
| 2020-12-31 | $8.19K 10-K · filed 2022-03-30 |
| 2019-12-31 | $8.10K 10-K · filed 2021-03-26 |
| 2018-12-31 | $7.88K 10-K · filed 2020-03-30 |
| 2017-12-31 | $8.08K 10-K · filed 2019-03-28 |
| 2016-12-31 | $7.90K 10-K · filed 2018-04-02 |
| 2015-12-31 | $4.14K 10-K · filed 2017-03-31 |
| 2014-12-31 | $7.82K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |